Lucida Medical

UK healthtech startup Lucida Medical has successfully closed an £8.7 million funding round led by IW Capital, with additional participation from XTX Ventures and Macmillan Cancer Support, to expand its AI-driven cancer diagnostics platform.

Summary of transaction details:

• Value: £8.7 Million
• Sector: Healthcare & Biotech
• Advisor: Not disclosed
• Key Entities: Lucida Medical, IW Capital, XTX Ventures, Macmillan Cancer Support
• Location: United Kingdom

Note: The capital injection will primarily fund the pursuit of US FDA regulatory clearance and the expansion of the company's Pi™ diagnostic platform beyond prostate cancer, addressing critical radiologist shortages and diagnostic delays within the NHS and broader healthcare markets.